Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Ashley Birkett, director of PATH’s Malaria Vaccine Initiative, is quoted in this article highlighting early results on RTS,S (the world’s first malaria vaccine) and the potential impact of combining the vaccine with seasonal malaria chemoprevention.
    Published: September 2021
  2. Rapid tests can help you stay safe in the Delta outbreak. But you have to use them correctly. Neha Agarwal, associate director of PATH’s Diagnostics program, highlights infrastructure obstacles to accessing at-home testing.
    Published: August 2021
  3. PATH's Director of Advocacy and Public Policy Heather Ignatius writes about why funding CEPI is imperative to ensure the development of the vaccines we need — not only to control COVID-19 in the U.S. today, but to bring an end to the pandemic globally.
    Published: August 2021
  4. Dr. Nanthalile Mugala, chief of the Africa region, speaks with Devex about PATH’s new five-year strategy and the importance of prioritizing local talent, local leadership, and local industry in global health programming.
    Published: August 2021

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

970 Item s
970 Item s
    Date
    From
    To
  1. PATH, as a major sub-partner on the consortium led by FHI360, launches the STRengthening Infectious disease DEtection Systems (STRIDES) Activity: a new Activity funded by USAID to combat epidemics, pandemics, and novel infectious disease threats.
    Published: November 2024
    Press Release
  2. Published: October 2024
    Announcement
  3. The trial aimed to determine how well a new, injectable, non-replicating rotavirus vaccine candidate works, compared to a licensed oral rotavirus vaccine in preventing infant diarrhea.
    Published: October 2024
    Announcement
  4. Published: October 2024
    Announcement
  5. Published: October 2024
    Press Release